SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back




Title
: Emerging Challenges in Primary Care 2018 Uniondale, NY
Activity/Course #:
: 10.06.18PC
Cost:
: Free
Release/Start Date:
: Oct 06 2018
Expiration Date:
: Oct 06 2018
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 7.0 hours
Credit(s):
: 7.0 AMA PRA Category I Credit(s)
7.0 AANP Contact hour(s)
2.5 ABIM MOC for physicians
2.5 ANCC with 2.0 hours pharmacotherapy for ARNPs
Hardware/Software Requirements:
This activity is jointly provided by National Association for Continuing Education, Postgraduate Institute for Medicine and DKBmed.
 
Saturday, October 6, 2018
Long Island Marriott Hotel & Conference Center
101 James Doolittle Boulevard
Uniondale, NY 11553
(516) 794-3800

Registration Fee
There is no registration fee for this activity.

Special Accommodations
NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking
Complimentary self-parking is available at the hotel.

Program Summary
Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.Learning Objectives

Learning Objectives
At the conclusion of this program, participants should be able to:

  1. Identify the barriers between clinicians and patients to discussing and initiating earlier insulin therapy for diabetes management; Discuss currently available basal and ultrabasal insulins and their pharmacokinetic/ pharmacodynamic profiles Recognize the prevalence and clinical impact of hypoglycemia in special populations at risk; Describe how best to initiate, utilize and intensify insulin therapy in patients with diabetes while incorporating treatment guidelines and unique patient needs; Integrate strategies to improve the patient experience with, and adherence to, insulin therapy.
  2. Recognize the importance of early identification of patients with potential idiopathic pulmonary fibrosis (IPF); Utilize appropriate strategies to diagnose a patient with IPF while excluding other potential mimickers; Discuss the available therapeutic options for patients with IPF; Recognize the role of the primary care clinician in managing the multi-morbidities associated with IPF.
  3. Assess patients for treatment with ER/LA opioid analgesics; Evaluate and initiate therapy, modify dose, and discontinue use of ER/LA opioid analgesics; Manage ongoing therapy with ER/LA opioid analgesics; Perform effective counseling with patients and caregivers about the safe use of ER/LA opioid analgesics, including proper storage and disposal; Identify general and product-specific drug information concerning ER/LA opioid analgesics.
  4. Describe the findings from recent trials of PCSK9i hypercholesterolemia treatments on cardiovascular outcomes; Discuss current guidelines and recommendations on the management of hyperlipidemia in high risk patients; Incorporate current data into secondary prevention treatment strategies for patients with the highest cardiovascular risk; Recognize barriers to access for PCSK9 monoclonal antibody therapy and discuss novel strategies to overcome them.
 
Agenda*

7:30-8:00

  Continental Breakfast and Registration
8:00-8:10   Welcome Remarks
Gregg Sherman, MD
8:10-9:40   Getting Comfortable with Insulin: New Approaches to Getting Patients Safely to Target
Javier Morales, MD
9:40-10:50   Navigating the Maze of Interstitial Lung Disease: Improving Outcomes through Early Diagnosis Care
Arunabh Talwar, MD, FCCP
10:50-11:10   Break
11:10-12:30   Safe Means of Administering the Right Therapy – Extended-Release and Long-Acting Opioids (Get SMART – Part I)
Michael R. Clark, MD, MPH, MBA and Yvonne D'Arcy, MS, ARNP-C, CNS, FAANP
12:30-1:30  

Lunch

1:30-2:45   Safe Means of Administering the Right Therapy – Extended-Release and Long-Acting Opioids (Get SMART – Part II)
Michael R. Clark, MD, MPH, MBA and Yvonne D'Arcy, MS, ARNP-C, CNS, FAANP
 2:45-3:55  

Managing Lipids and Cardiovascular Risk: Using the Data to Optimize Care
Ola Akinboboye, MD, MPH, MBA

 3:55-4:00 

Program Summary and Closing Remarks
Gregg Sherman, MD

 
*Agenda subject to change.
 
Faculty

Ola Akinboboye, MD, MPH, MBA
Associate Professor of Clinical Medicine
Cornell University
Past President, Association of Black Cardiologists
Medical Director, Queens Heart Institute
Rosedale, NY

Michael R. Clark, MD, MPH, MBA
Chair, Psychiatry & Behavioral Health
Inova Health System
Falls Church, VA

Yvonne D'Arcy, MS, ARNP-C, CNS, FAANP
Pain Management Nurse Practitioner
Ponte Vedra Beach, FL

Javier Morales, MD, FACP, FACE
Clinical Associate Professor of Medicine
Donald and Barbara Zucker School of Medicine At Hofstra/Northwell University
Vice President
Advanced Internal Medicine Group, P.C.
East Hills, NY

Arunabh Talwar, MD, FCCP
Director, Pulmonary Hypertension and Advanced Lung Disease Program
North Shore University Hospital, Manhasset, New York
Professor Of Medicine
Hofstra Northwell School of Medicine
Hofstra University
Hempstead, NY

Planning Committee

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL


Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education

Plantation, FL

Sandy Bihlmeyer, M.Ed.
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education

Plantation, FL

Cassandra A. McCullough, MBA

Chief Executive Officer
Association of Black Cardiologists
New York, NY

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education

Plantation, FL

Sponsored and Certified By
National Association for Continuing Education and Postgraduate Institute for Medicine
Accreditation Designation Statement
The Association of Black Cardiologists, Inc.
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Postgraduate Institute for Medicine
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBmed. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 2.5 contact hours.
Designated for 2.0 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.

National Association for Continuing Education
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 7.0 Contact hour(s) of continuing education (which includes pharmacology hours).
Faculty Disclosure Policy
It is the policy of NACE to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by NACE are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Commercial Support
This activity is supported by educational funding provided by Amgen, an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc., an educational grant from Sanofi US and Regeneron Pharmaceuticals, an educational grant from Sanofi US, and an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

This activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies. Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).